Interact to see
Advertisement
Advertisement
NUV vs RMI
NUV vs RMI Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
NUV vs. RMI commentary
Jul 27, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NUV is a Hold and RMI is a Hold.
SUMMARIES
FUNDAMENTALS
Fundamentals
NUV has more net assets: 1.83B vs. RMI (96.8M). NUV has a higher annual dividend yield than RMI: NUV (2.068) vs RMI (-3.473). NUV was incepted earlier than RMI: NUV (38 years) vs RMI (7 years). NUV (0.47) has a lower expense ratio than RMI (3.01). RMI has a higher turnover NUV (21.00) vs NUV (21.00).
| NUV | RMI | NUV / RMI | |
| Gain YTD | 2.068 | -3.473 | -60% |
| Net Assets | 1.83B | 96.8M | 1,892% |
| Total Expense Ratio | 0.47 | 3.01 | 16% |
| Turnover | 21.00 | 66.00 | 32% |
| Yield | 4.22 | 1.38 | 306% |
| Fund Existence | 38 years | 7 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| NUV | RMI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 70% | N/A |
| Stochastic ODDS (%) | 2 days ago 82% | 2 days ago 82% |
| Momentum ODDS (%) | 2 days ago 69% | 2 days ago 81% |
| MACD ODDS (%) | 2 days ago 76% | 2 days ago 69% |
| TrendWeek ODDS (%) | 2 days ago 70% | 2 days ago 74% |
| TrendMonth ODDS (%) | 2 days ago 74% | 2 days ago 73% |
| Advances ODDS (%) | 2 days ago 76% | 24 days ago 87% |
| Declines ODDS (%) | 4 days ago 76% | 9 days ago 80% |
| BollingerBands ODDS (%) | 2 days ago 83% | 2 days ago 84% |
| Aroon ODDS (%) | 2 days ago 70% | 2 days ago 76% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ASVIX | 10.10 | 0.06 | +0.60% |
| American Century Small Cap Value Inv | |||
| VITSX | 152.68 | 0.67 | +0.44% |
| Vanguard Total Stock Market Idx I | |||
| GCLLX | 17.21 | 0.06 | +0.35% |
| Goldman Sachs Enhanced U.S. Equity C | |||
| VECRX | 22.33 | 0.07 | +0.31% |
| Virtus KAR Equity Income R6 | |||
| FBTTX | 25.58 | N/A | N/A |
| Fidelity Advisor Biotechnology M | |||